116 related articles for article (PubMed ID: 33421131)
21. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
[TBL] [Abstract][Full Text] [Related]
22. Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas.
Psarras K; Ueda M; Yamamura T; Ozawa S; Kitajima M; Aiso S; Komatsu S; Seno M
Protein Eng; 1998 Dec; 11(12):1285-92. PubMed ID: 9930679
[TBL] [Abstract][Full Text] [Related]
23. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.
Lorimer IA; Keppler-Hafkemeyer A; Beers RA; Pegram CN; Bigner DD; Pastan I
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14815-20. PubMed ID: 8962138
[TBL] [Abstract][Full Text] [Related]
24. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
[TBL] [Abstract][Full Text] [Related]
25. Structural Analyses of An Epidermal Growth Factor Receptor-Specific Single-Chain Fragment Variable via An In Silico Approach.
Mahgoub EO; Kulkarni S
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38009747
[TBL] [Abstract][Full Text] [Related]
26. Production and Conjugation of Truncated Recombinant Diphtheria Toxin to VEGFR-2 Specific Nanobody and Evaluation of its Cytotoxic Effect on PC-3 Cell Line.
Shajari S; Farajollahi MM; Behdani M; Tarighi P
Mol Biotechnol; 2022 Nov; 64(11):1218-1226. PubMed ID: 35478310
[TBL] [Abstract][Full Text] [Related]
27. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
[TBL] [Abstract][Full Text] [Related]
28. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
[TBL] [Abstract][Full Text] [Related]
29. Ribonucleases as novel chemotherapeutics : the ranpirnase example.
Lee JE; Raines RT
BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091
[TBL] [Abstract][Full Text] [Related]
30. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
Heitner T; Moor A; Garrison JL; Marks C; Hasan T; Marks JD
J Immunol Methods; 2001 Feb; 248(1-2):17-30. PubMed ID: 11223066
[TBL] [Abstract][Full Text] [Related]
31. Engineering Human Pancreatic RNase 1 as an Immunotherapeutic Agent for Cancer Therapy Through Computational and Experimental Studies.
Nassiri M; Ghovvati S; Gharouni M; Tahmoorespur M; Bahrami AR; Dehghani H
Protein J; 2024 Apr; 43(2):316-332. PubMed ID: 38145445
[TBL] [Abstract][Full Text] [Related]
32. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
33. Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro.
Mironova KE; Proshkina GM; Ryabova AV; Stremovskiy OA; Lukyanov SA; Petrov RV; Deyev SM
Theranostics; 2013; 3(11):831-40. PubMed ID: 24312153
[TBL] [Abstract][Full Text] [Related]
34. An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.
Kiesgen S; Arndt MAE; Körber C; Arnold U; Weber T; Halama N; Keller A; Bötticher B; Schlegelmilch A; Liebers N; Cremer M; Herold-Mende C; Dyckhoff G; Federspil PA; Jensen AD; Jäger D; Kontermann RE; Mier W; Krauss J
Cancer Lett; 2015 Feb; 357(1):364-373. PubMed ID: 25434798
[TBL] [Abstract][Full Text] [Related]
35. A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.
Rezaie E; Amani J; Bidmeshki Pour A; Mahmoodzadeh Hosseini H
Eur J Pharmacol; 2020 Mar; 870():172912. PubMed ID: 31926992
[TBL] [Abstract][Full Text] [Related]
36. The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma.
Huang S; Jiang C; Zhang H; Bell T; Guo H; Liu Y; Yao Y; Zeng D; Ahmed M; Nomie K; Zhang L; Wang M
Blood Cancer J; 2018 Mar; 8(3):33. PubMed ID: 29559616
[No Abstract] [Full Text] [Related]
37. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
[TBL] [Abstract][Full Text] [Related]
38. Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40).
Shilova ON; Souslova EA; Pilunov AM; Deyev SM; Petrov RV
Dokl Biochem Biophys; 2016 Nov; 471(1):450-453. PubMed ID: 28058684
[TBL] [Abstract][Full Text] [Related]
39. Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy.
Nassiri M; Behnam-Rasouli R; Vakili-Azghandi M; Gopalan V; Dolati P; Nourmohammadi R
Life Sci; 2022 Jan; 289():120222. PubMed ID: 34902436
[TBL] [Abstract][Full Text] [Related]
40. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.
Itai S; Yamada S; Kaneko MK; Chang YW; Harada H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):272-281. PubMed ID: 29090976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]